CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload

被引:39
|
作者
Fontes, Magda S. C. [1 ]
Kessler, Elise L. [1 ]
van Stuijvenberg, Leonie [1 ]
Brans, Maike A. [1 ]
Falke, Lucas L. [2 ]
Kok, Bart [1 ]
Leask, Andrew [3 ]
van Rijen, Harold V. M. [1 ]
Vos, Marc A. [1 ]
Goldschmeding, Roel [2 ]
van Veen, Toon A. B. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[3] Univ Western Ontario, Dept Dent, London, ON N6A 3K7, Canada
关键词
CTGF; Fibrosis; Hypertrophy; Arrhythmias; TISSUE GROWTH-FACTOR; CX43; EXPRESSION; TGF-BETA; CCN2; DYSFUNCTION; CONDUCTION; MYOCYTES;
D O I
10.1016/j.yjmcc.2015.09.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: One of the main contributors to maladaptive cardiac remodeling is fibrosis. Connective tissue growth factor (CTGF), a matricellular protein that is secreted into the cardiac extracellular matrix by both cardiomyocytes and fibroblasts, is often associated with development of fibrosis. However, recent studies have questioned the role of CTGF as a pro-fibrotic factor. Therefore, we aimed to investigate the effect of CTGF on cardiac fibrosis, and on functional, structural, and electrophysiological parameters in a mouse model of CTGF knockout (1(0) and chronic pressure overload. Methods and results: A new mouse model of global conditional CTGF KO induced by tamoxifen-driven deletion of CTGF, was subjected to 16 weeks of chronic pressure overload via transverse aortic constriction (TAC, control was sham surgery). CTGF KO TAC mice presented with hypertrophic hearts, and echocardiography revealed a decrease in contractility on a similar level as control TAC mice. Ex vivo epicardial mapping showed a low incidence of pacing-induced ventricular arrhythmias (2/12 in control TAC vs. 0/10 in CTGF MO TAC, n.s.) and a tendency towards recovery of the longitudinal conduction velocity of CTGF KO TAC hearts. Picrosirius Red staining on these hearts unveiled increased fibrosis at a similar level as control TAC hearts. Furthermore, genes related to fibrogenesis were also similarly upregulated in both TAC groups. Histological analysis revealed an increase in fibronectin and vimentin protein expression, a significant reduction in connexin43 (0;43) protein expression, and no difference in Na(v)1.5 expression of CTGF MO ventricles as compared with sham treated animals. Conclusion: Conditional CTGF inhibition failed to prevent TAC-induced cardiac fibrosis and hypertrophy. Additionally, no large differences were found in other parameters between CTGF MO and control TAC mice. With no profound effect of CTGF on fibrosis formation, other factors or pathways are likely responsible for fibrosis development. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:82 / 90
页数:9
相关论文
共 50 条
  • [1] Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis
    Xu, Qi
    Lekgabe, Edna D.
    Gao, Xiao-Ming
    Ming, Ziqiu
    Tregear, Geoffrey W.
    Dart, Anthony M.
    Bathgate, Ross A. D.
    Samuel, Chrishan S.
    Du, Xiao-Jun
    ENDOCRINOLOGY, 2008, 149 (02) : 476 - 482
  • [2] CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload
    Gravning, Jorgen
    Ahmed, Mohammed Shakil
    von Lueder, Thomas G.
    Edvardsen, Thor
    Attramadal, Havard
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2049 - 2056
  • [3] Reversibility of cardiac fibrosis and hypertrophy after chronic pressure overload
    Beetz, N. B.
    Rylski, B. R.
    Beyersdorf, F. B.
    Hein, L. H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 51 - 51
  • [4] Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis
    Gao, Xiao-Ming
    Wong, Geoffrey
    Wang, Binghui
    Kiriazis, Helen
    Moore, Xiao-Lei
    Su, Yi-Dan
    Dart, Anthony
    Du, Xiao-Jun
    JOURNAL OF HYPERTENSION, 2006, 24 (08) : 1663 - 1670
  • [5] Knockout of β1- and β2-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis
    Kiriazis, H.
    Wang, K.
    Xu, Q.
    Gao, X-M
    Ming, Z.
    Su, Y.
    Moore, X-L
    Lambert, G.
    Gibbs, M. E.
    Dart, A. M.
    Du, X-J
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (04) : 684 - 692
  • [6] Genetic knockout of prestin limits cardiac hypertrophy in a murine pressure overload model
    Thai, Phung N.
    Ren, Lu
    Lyu, Yankun
    Diloretto, Daphne A.
    Timofeyev, Valeriy
    Yamoah, Ebenezer N.
    Zhang, Xiao-Dong
    Chiamvimonvat, Nipavan
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 87A - 87A
  • [7] Cathepsin K Knockout Alleviates Pressure Overload-Induced Cardiac Hypertrophy
    Hua, Yinan
    Xu, Xihui
    Shi, Guo-Ping
    Chicco, Adam J.
    Ren, Jun
    Nair, Sreejayan
    HYPERTENSION, 2013, 61 (06) : 1184 - +
  • [8] Genetic Knockout of Prestin Limits Cardiac Hypertrophy in a Murine Pressure Overload Model
    Thai, Phung N.
    Ren, Lu
    Lyu, Yankun
    Diloretto, Daphne A.
    Timofeyev, Valeriy
    Yamoah, Ebenezer N.
    Zhang, Xiao-Dong
    Chiamvimonvat, Nipavan
    CIRCULATION RESEARCH, 2022, 131 (12) : E181 - E182
  • [9] Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
    Xu, Si-Chi
    Ma, Zhen-Guo
    Wei, Wen-Ying
    Yuan, Yu-Pei
    Tang, Qi-Zhu
    PPAR RESEARCH, 2017, 2017
  • [10] The effects of BH4 treatment in the development of the cardiac hypertrophy and fibrosis by chronic pressure overload in rats
    Kumagai, Sumito
    Ishibashi, Masaaki
    Hiroi, Toshihitc
    Wajima, Teruaki
    Ishii, Masakazu
    Kiuchi, Yuji
    Shimizu, Shunichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 266P - 266P